| Monday 5 December | ||
| 2:30 - 4:30pm | Registration Poster Set Up |
Level 2 Foyer |
| 4:30 - 4:45pm | Welcome and Official Opening AVS11 Meeting Convenor, Assoc Prof Lara Herrero AVS President, Prof Heidi Drummer |
Grand Ballroom |
| 4:45 - 5:15pm | AVS Over the Years Prof Paul Young, The University of Queensland Chair: Assoc Prof Lara Herrero, Griffith University |
Grand Ballroom |
| 5:15 - 6:15pm | International Guest Speaker Structure-based Immunogen Design Prof Jason McLellan, University of Texas, Austin USA Chair: Prof Paul Young, The University of Queensland With thanks to our Opening Keynote Sponsor 
|
Grand Ballroom |
| Welcome Mixer As a nod to the fi rst ever AVS Meeting, we invite you to don a Hawaiian/ colourful shirt for the Welcome Mixer. A prize to be won for the ‘loudest’ shirt of the night! With thanks to our Welcome Mixer Sponsor  |
JW Marriott, Poolside | |
| Tuesday 6 December | ||
| 8:30 - 10:00am | Session 1: Animal and Wildlife Viruses Chairs: Dr Glenn Marsh, CSIRO Dr Turgut Aktepe, University of Melbourne, Melbourne Veterinary School Invited Speaker: Uncovering the viromes of fish, amphibians and reptiles using metatranscriptomics and metagenomics Prof Peter White, University of New South Wales Unearthing the diversity of ancient retroviruses in Australian marsupials Emma Harding, UNSW Sydney Latid herpesvirus 1 — a novel virus that could threaten the Australian barramundi industry Lewis Mercer, UNSW Sydney Koala retrovirus genetic diversity and transmission dynamics within captive koala populations Briony Joyce, The University of Queensland Metagenomic detection and characterisation of many viruses, including human adenoviruses, in apparently healthy Australian Neophema birds Subir Sarker, La Trobe University |
Grand Ballroom |
| 10:00 - 10:30am | Morning Refreshments | Tambourine & Ballroom Foyers |
| 10:30 - 12:00pm | Session 2: Innate Immunity Chairs: Prof Michael Beard, University of Adelaide Dr Svenja Fritzlar, The University of Melbourne Invited Speaker: Leveraging airway innate immunity to protect against respiratory viruses Assoc Prof Nathan Bartlett, University of Newcastle Targeting viral immune evasion for attenuated ‘live’ vaccine design Greg Moseley, Monash University Lipid droplets contribute to an antiviral bystander effect during infection Ebony Monson, La Trobe University P38 kinases mediate NLRP1 inflammasome activation after ribotoxic stress response and virus infection Florian I Schmidt, University of Bonn Exploring TRIM proteins as targets for broad spectrum antivirals Rubaiyea Farrukee, The University of Melbourne |
Grand Ballroom |
| 12:00 - 1:00pm | Lunch | Tambourine & Ballroom Foyers |
| 12:15 - 12:45pm | ECR - Meet the Professors | Grand Ballroom |
| 1:00 - 2:30pm | Session 3: Antivirals and vaccines Chairs: Assoc Prof Branka Grubor, University of Adelaide Dr Emma Grant, La Trobe University With thanks to our Session Sponsor 
Invited Speaker: Rational treatment strategies for SARS-CoV-2 derived from studies in human pluripotent stem cell models Prof Kanta Subbarao, The Peter Doherty Institute for Infection and Immunity Incorporation of SARS-CoV-2 Spike NTD to RBD-Based Vaccine Improves Immunity and Protection Against Variants of Concern Lisa Connor, Victoria University of Wellington Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques Brendon Chua, The University of Melbourne A Platform Technology for Generating Subunit Vaccines Against Diverse Viral Pathogens Andrew Young, The University of Queensland A combination of molnupiravir and oseltamivir is superior to either drug alone for the treatment of influenza in ferrets Paulina Koszalka, WHO Collaborating Centre for Reference and Research on Influenza |
Grand Ballroom |
| 2:30 - 3:00 | Afternoon Refreshments | Tambourine & Ballroom Foyers |
| 3:00 - 4:30 | Session 4: Virus Structures, Receptors, Assembly and Replication Chairs: Assoc Prof Daniel Waterson, University of Queensland Alice Trenerry, University of Melbourne Invited Speaker: Structural basis for MERS-CoV ORF4b binding to the nuclear import receptor imp-alpha Prof Jade Forwood, Charles Sturt University Investigation of SARS-CoV-2 Variants of Concern to identify determinants of transmissibility and virulence Andrew Davidson, University of Bristol Live Cell Imaging of Hepatitis B Virus covalent closed circular DNA Xiaonan Zhang, University of Canberra Near-Atomic Structures of Emerging Japanese Encephalitis Virus Genotypes Reveal Important Epitope & Antigenic Differences Morgan Freney, The University of Queensland Envelope protein domain III is a key determinate of Yellow Fever Virus structure Summa Bibby, The University of Queensland |
Grand Ballroom |
| 4:30 - 5:00 | Free Time | |
| 5:00 - 6:00pm | International Guest Speaker Understanding pandemic viruses Prof Wendy Barclay, Imperial College, London Chair: Dr Sarah Londrigan, The University of Melbourne |
Grand Ballroom |
| 6:00 - 6:30pm | Science Bites Chairs: Camille Esneau, University of Newcastle Wesley Freppell, Griffith University Immune Priming as a Strategy to Prevent HaHV-1 Infection in Australian Abalone Jacinta Agius, La Trobe University Identifying introduced and novel viruses in small mammals on the island of Tasmania Erin Harvey, The University of Sydney The Interactions between Probiotic Bacteria and Respiratory Viruses within the Epithelium of the Upper Respiratory Tract Tejasri Yarlagadda, The Queensland University of Technology Tetravalent microprojection-based dengue chimeric virus vaccine raises potent neutralising antibodies in mice Jovin Choo, The University of Queensland Mitigating the risk of infectious virus in aerosols Leo Lee, The University of Melbourne Rapid, isothermal detection of Zika virus: a potential alternative to RTPCR Rickyle Balea, The University of the Sunshine Coast Reconstructing ancestral flaviviruses to fight current and future flavivirus outbreaks Natalee Newton, The University of Queensland The Middle East Respiratory Syndrome Coronavirus ORF4b binds host importin alpha isoforms via an unusual mechanism to inhibit innate immunity Thilini Surenika Munasinghe, School of Dentistry and Medical Sciences, Charles Sturt University |
Grand Ballroom |
| 6:30 - 7:30pm | Poster Session | Refreshments served With thanks to our Poster Session Sponsor 
|
Tambourine Gallery |
| Wednesday 7 December | ||
| 7:00 - 8:00am | Breakfast Session CV Builder for ECRs Prof Katherine Andrews, Griffith University With thanks to our ECR Career Development Sponsor 
|
Grand Ballroom |
| 8:30 - 10:00am | Session 5: Viral Epidemiology and Diagnostics Chairs: Prof Peter White, UNSW Sydney Dr Bethany Horsburgh, Kirby Institute With thanks to our Session Sponsor 
Invited Speaker: Infectious Diseases in Africa: Friend or Foe Dr Belinda Herring, WHO Regional Office for Africa Integration of innovative platform technologies for the diagnosis of flaviviral infections Ryan Johnston, The University of Queensland Development of a novel adaptable whole genome sequencing assay for HIV and HCV Bethany Horsburgh, Kirby Institute The Host Response as a Novel Diagnostic Biomarker for ‘PreSymptomatic’ COVID-19 Georgina McCallum, The University of Queensland A novel chimeric virus for vaccine and diagnostic application for the Japanese encephalitis virus outbreak in Australia Jessica Harrison, University of Queensland |
Grand Ballroom |
| 10:00 - 10:30am | Morning Refreshments | Tambourine & Ballroom Foyers |
| 10:30 - 12:00pm | Session 6: Systems Virology and Viromes Chairs: Prof Andrew Harman, University of Sydney Dr Rhys Parry, The University of Queensland Invited Speaker: Towards an understanding of virus ecology in wildlife: from “one hostone virus” models to viromes Dr Michelle Wille, The University of Sydney Illuminating the unseen majority beneath our feet – enumeration of the global virome using intelligent algorithms Richard Allen White III, UNCC The lipidome of lipid droplets changes significantly during viral infection in the brain Zahra Telikani, La Trobe University Dengue virus evolution to Wolbachia; a potential Achilles’ heel Kathryn Edenborough, Monash University Zika virus noncoding RNA cooperates with the viral protein NS5 to inhibit STAT1 phosphorylation and facilitate viral pathogenesis Andrii Slonchak, The University of Queensland |
Grand Ballroom |
| 12:00 - 1:30pm | Lunch | Tambourine and Ballroom Foyers |
| 12:15 - 1:15pm | Panel session for ECRs on career development Belinda Herring WHO, Simone Vink Davies Collison Cave, Julianne Bayliss CSL, Miguel Quinones-Mateu The University of Otago, Tony Cunningham University of Sydney, Katherine Andrews Griffi th University Chair: Emma Harding, UNSW Sydney With thanks to our ECR Career Development sponsor
|
Grand Ballroom |
| 1:30 - 3:00pm | Session 7: Viral Host Interactions Chairs: Assoc Prof Jill Carr, Flinders University Dr Ebony Monson, La Trobe University Invited Speaker: Exploring dengue virus (DENV) NS1 protein biology and antiviral drug development using infectious tagged reporter viruses Dr Nicholas Eyre, Flinders University MicroRNAs: Macro Roles in Insect Host-Virus Interactions? Daniel Chew, The University of Queensland New insights into the dynamics of sexual transmission of HIV Andrew Harman, University of Sydney Using natural history to determine the risk of dengue virus escape from Wolbachia in Aedes aegypti mosquitoes Johanna Fraser, Monash University Does SARS-CoV-2 infect the brain? Evidence of in-host neurotropic adaptation and ACE2-independent infection Daniel Rawle, QIMR Berghofer Medical Research Institute |
Grand Ballroom |
| 3:00 - 3:30pm | Afternoon Refreshments | Tambourine & Ballroom Foyers |
| 3:30 - 5:00pm | Session 8: Viral Immunology Chairs: Prof Allison Abendroth, The University of Sydney Dr Jennifer Juno, The University of Melbourne With thanks to our Session Sponsor
Invited Speaker: CD8+ T cell immunity in viral infection and vaccination Prof Katherine Kedzierska, The Peter Doherty Institute for Infection & Immunity Mucosal inflammatory and antibody responses associated with protection and disease after human SARS-CoV-2 challenge Ryan Thwaites, Imperial College London Influenza-specific CD8+ T cells across the human lifespan: a suboptimal reset for the elderly Carolien Van De Sandt, University of Melbourne Immune responses in the respiratory tract and blood of COVID-19 patients reveal mechanisms of disease severity Wuji Zhang, University of Melbourne Characterising the Initial Events of Herpes Simplex Virus Infection in Human Anogenital Tissue Hafsa Rana, Westmead Institute for Medical Research |
Grand Ballroom |
| 5:00 - 5:30pm | Science Bites Chairs: Camille Esneau, University of Newcastle Wesley Freppell, Griffith University Identification of dengue virus (DENV) NS1 protein residues that are critical to its secretion Brandon E K Tan, University of Adelaide Structural characterisation of the lyssavirus N0P complex reveals a highly conserved interface Camilla Donnelly, Charles Sturt University/CSIRO Post Graduate Student TMEM41B and VMP1 modulate cellular lipid and energy metabolism for facilitating dengue virus infection Meisam Yousefi, Duke-NUS Medical School A new recombinant alphavirus platform based on the insect-specific Yada Yada virus Mikaela Bell, The University of Queensland Lagovirus protein p23 is a viroporin Elena Smertina, CSIRO Neuropathogenesis: Mousing around with henipaviruses Sarah Edwards, CSIRO Characterising inflammatory mechanisms in long COVID Jane Sinclair, The University of Queensland, School of Chemistry and Molecular Bioscience Repurposed MCC950 and VX-765 provide survival advantage in prophylactically treated SARS-CoV-2 infected K18-hACE2 mice Aroon Supramaniam, Menzies Health Institute Queensland |
Grand Ballroom |
| 5:30 - 6:30pm | Poster Session | Refreshments served With thanks to our Poster Session Sponsor 
|
Tambourine Gallery |
| Thursday 8 December | ||
| 7:45 | A light breakfast of croissants, tea and coffee served in the Ballroom foyer | |
| 8:00 - 9:00am | Session 9 (a): Antiviral and Vaccines II Chair: Prof Karla Helbig, La Trobe University T cell vaccines against Zika virus Branka Grubor-Bauk, University of Adelaide SARS-CoV-2 virus-like particles as a candidate for the second generation of vaccines against COVID-19 Julio Carrera-Montoya, University of Melbourne Engineered cellular exosome therapeutics to treat viral infections Kevin Morris, Griffith University Micro-projection Array Patch Delivery of Measles and Rubella Vaccine in a Phase I Clinical Trial Imogen Bermingham, Vaxxas Pty Ltd |
Ballroom 1 |
| Session 9 (b): Viral Immunology II Chair: Assoc Prof Rowena Bull, UNSW Sydney COVID-19 vaccination induces robust SARS-CoV-2 T cell responses in blood cancer patients in the presence and absence of B cells Oanh Nguyen, The University of Melbourne A broadly applicable subunit vaccine platform to safeguard against future viral pandemics Keith Chappell, University of Queensland Influenza virus infection induces high levels of CD52 expression on effector CD8+ T cells in the infected lung So Young Chang, The University of Melbourne, Peter Doherty Institute for Infection and Immunity Increased immunopathology and perturbed immune dynamics during influenza virus and arbovirus co-infection Isabelle Foo, The Peter Doherty Institute for Infection and Immunity |
Ballroom 2 | |
| 9:00 – 10:00 | Session 10 (a): Viral host interactions II Chair: Assoc Prof Lara Herrero, Griffith University Host glycocalyx captures HIV proximal to the cell surface via oligomannose-GlcNAc glycan-glycan interactions to support viral entry Belinda De Villiers, Griffith University, Institute for Glycomics Unravelling the antiviral mechanisms by which Wolbachia pipientis restricts dengue virus replication Robson Kriiger Loterio, Monash University Digital spatial profiling of the immune influx that occurs during chikungunya virus and o’nyong nyong virus infections Penny A Rudd, Griffith University Modulation of CD81 by the E3 ubiquitin ligase MARCH8 inhibits replication of HSV-1 – a novel mechanism of MARCH8-mediated virus restriction Patrick Reading, Who Collaborating Centre for Reference and Research on Influenza |
Ballroom 1 |
| Session 10 (b): Innate Immunology II Chair: Dr Sarah Londrigan, The University of Melbourne The multifaceted attack on MR1 antigen presentation by herpes simplex viruses Carolyn Samer, University of Sydney A novel mouse upper respiratory tract infection model with human coronavirus OC43 defines IFN-λ expression and TLR2/6 mediated innate immune activation Nathan Bryant, University of Newcastle Varicella Zoster Virus infects and functionally hijacks Mucosal Associated Invariant T cells Shivam Purohit, University of Sydney Lipid droplets act as platforms for innate immune signalling proteins Jay Laws, La Trobe University |
Ballroom 2 | |
| 10:00 - 10:30am | Morning Refreshments | Tambourine & Ballroom Foyers |
| 10:30 - 12:00pm | Session 11: Unusual Viruses, Phages and Plant Viruses Chairs: Dr Jody Peters, The University of Queensland Dr Stephanie Lynch, Westmead Institute for Medical Research With thanks to our Session Sponsor 
Invited Speaker: Sequence to biology of fungal and phytophthora viruses Assoc Prof Robin MacDiarmid, The New Zealand Institute for Plant & Food Research Limited Structural insights into the origins and lifestyle of persistent plant partitiviruses Frank Sainsbury, Griffith University Jingmenviruses: ubiquitous, understudied, segmented flavi-like viruses Agathe Colmant, Aix-Marseille University Meta-transcriptomic analysis of wild animal gut content is a useful strategy for the surveillance of plant pathogens in Australia Jackie Mahar, University of Sydney Evolution of grapevine leafroll-associated virus 3: genetic diversity and virulence Roshni Rohra, The New Zealand Institute of Plant & Food Research Ltd |
Grand Ballroom |
| 12:00 - 1:15pm | Lunch | Tambourine & Ballroom Foyers |
| 12:15 - 1:15pm | AVS AGM | Grand Ballroom |
| 1:15 - 2:45pm | Session 12: Focus on virology in First Nation communities Chairs: Prof Jason Mackenzie, The University of Melbourne Dr Louise Rowntree, The University of Melbourne With thanks to our Session Sponsor 
Invited Speaker: Prof James Ward, The University of Queensland Chronic immune activation and T-cell dysfunction mediated from the HTLV-1c provirus graveyard Ashley Hirons, The University of Melbourne Working towards 95% coverage for influenza-specific CD8+ T cell immunity in Indigenous Australians Louise Rowntree, The University of Melbourne Robust and prototypical immune responses towards COVID-19 BNT162b2 vaccine in First Nations Australian people can be impacted by comorbidities Wuji Zhang, University of Melbourne Structure of the HTLV-1 Capsid Reveals a Druggable Pocket David Jacques, UNSW Sydney |
Grand Ballroom |
| 2:45 - 3:15pm | Afternoon Refreshments | Tambourine & Ballroom Foyers |
| 3:15 - 4:45pm | Session 13: Clinical Virology Chairs: Prof Tony Cunningham, The Westmead Institute for Medical Research Dr Ki Wook Kim, UNSW Sydney Invited Speaker: HTLV1 a neglected cause of morbidity and mortality Assoc Prof Lloyd Einsiedel, Doherty Institute Does Human Papillomavirus use a ‘Hit and Run’ mechanism in head and neck cancer pathogenesis? Danyelle Ferreira, Griffith University Phage Australia: Building a phage therapy centre Stephanie Lynch, Westmead Institute for Medical Research Identifying the neurological impact of COVID-19 in a mouse of model of SARS-CoV-2 infection Julie McAuley, The University of Melbourne A role for gut barrier breakdown in severe dengue disease Kate Stacey, University of Queensland |
Grand Ballroom |
| 4:45 - 5:00pm | AVS11 Meeting Concludes | Grand Ballroom |
| 7:15pm | AVS11 Dinner If you have booked a ticket for the dinner, you will have a knife and fork icon on your name badge. Dress: Smart casual |
Grand Ballroom |
Programadmin2022-12-02T05:34:03+00:00